Transarterial chemoembolization (TACE) plus tyrosine kinase inhibitors versus TACE in patients with hepatocellular carcinoma: a systematic review and meta-analysis

PURPOSE: Transarterial chemoembolization (TACE) with tyrosine kinase inhibitors (TKIs) has been increasingly used to treat unresectable hepatocellular carcinoma (uHCC). However, the superiority of combination therapy to TACE monotherapy remains controversial. Therefore, here we performed a meta-anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Ruihua, Gong, Fen, Wang, Yan, Huang, Caixia, Wu, Jiaming, Hu, Leihao, Liu, Min, Qiu, Shijun, Lu, Liming, Lin, Yisheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064711/
https://www.ncbi.nlm.nih.gov/pubmed/37004052
http://dx.doi.org/10.1186/s12957-023-02961-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064711/
https://www.ncbi.nlm.nih.gov/pubmed/37004052
http://dx.doi.org/10.1186/s12957-023-02961-7

Ejemplares similares